Charles River Laboratories Case Study
First time global consolidation
Charles River Laboratories
Charles River works with the pharmaceutical, research and biotechnology industries to drive the discovery, development and safe manufacture of new drug therapies.
Having grown from a family-owned company to a publicly traded $2.8 billion corporation operating in over 20 countries, Charles River wanted to consolidate their program globally for the first time.
Charles River’s objectives included cost savings, establishing strategic supplier relationships, improving program compliance, and strengthening service and convenience to travelers.
Providing support at every level
Having extensive experience with global consolidation for clients of similar size, FCM could combine industry best practices with fresh strategies.
A tailored account management structure was implemented at local, regional and multinational levels, whilst FCMs Reporting & Analytics technology gave Charles River new insight into their travel program. By using preferred suppliers, compliance was optimized; cost management and customer satisfaction were improved and sustainability and risk management initiatives to be implemented.
FCM has historically achieved savings of 9-15% for clients in their first year with a consolidated program. By negotiating agreements with airlines, hotels and car rental providers, year-on-year savings of 48.8% were achieved.
By leveraging FCM’s virtual card technology, payment processes were simplified, time-consuming reconciliation reduced, and fraud risk eliminated.
FCM’s airfare re-shopping tool enabled Charles River to monitor airfare prices from ticketing to the day of departure, whilst FCM’s unused ticket tracker reports on all outstanding unused ticket credits, companywide.